Charles Lyons Receives Presidential Appointment as U.S. Alternate Representative on UNICEF Executive
September 13, 2011
FOR IMMEDIATE RELEASE
Contact: Robert Yule, 202-390-9540, email@example.com
Appointment Reinforces Collaboration on Shared Goal of Eliminating Pediatric HIV/AIDS
September 13, 20122, Washington, D.C. – The White House announced that U.S. President Barack Obama has appointed Charles “Chip” Lyons – President and CEO of the Elizabeth Glaser Pediatric AIDS Foundation – as United States Alternate Representative to the Executive Board on the United Nations Children’s Fund (UNICEF).
The Executive Board is the governing body of UNICEF, and is comprised of 36 governments representing the five regional groups of Member States at the United Nations. The Executive Board reviews UNICEF activities and approves its policies, country programs, and budgets.
The U.S. Head of Delegation to the UNICEF Executive Board is Carmen Lucca Nazario, former Assistant Secretary for Children and Families at the U.S. Department of Health and Human Services (HHS). Lyons will serve as the Alternate Head of Delegation.
“We welcome President Obama’s appointment of Chip Lyons as U.S. Alternate Representative on the UNICEF Executive Board. It is a reflection of Chip’s longtime commitment and leadership on issues affecting the world’s children,” said Dr. David Kessler, Chair of the Board of the Elizabeth Glaser Pediatric AIDS Foundation. “This appointment will also reinforce our joint collaboration with UNICEF, in particular on our shared goal of eliminating mother-to-child transmission of HIV.”
To read the announcement issued by the White House, visit www.whitehouse.gov/the-press-office/2011/09/09/president-obama-announces-more-key-administration-posts.
About the Elizabeth Glaser Pediatric AIDS Foundation:
The Foundation is a global leader in the fight against pediatric HIV and AIDS, and has reached more than 12.2 million women with services to prevent transmission of HIV to their babies. It currently works at more than 5,500 sites in 17 countries to implement prevention, care, and treatment services; to further advance innovative research; and to execute strategic and targeted global advocacy activities in order to bring dramatic change to the lives of millions of women, children, and families worldwide.